Company profile
Guided Therapeutics, Inc.
OTC: GTHP · Healthcare · Medical - Devices
#901 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
42DFH 25DQ 57GM 67SS 29
v0.1 · 65/100 weight · provisional
↑ revenue growth (YoY), 3-yr revenue growth · ↓ growth stability, workforce scale
Methodology →Revenue TTM
$650.0k
Rev growth YoY (TTM)
+450.8%
Net income (FY)
-$3.2M
Employees
3
as of 2026-08-21
Market cap
$26.1M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$767.0k$767.0k2025
Net income-$3.2M-$3.2M2025
Operating income-$2.4M-$2.4M2025
Total assets$1.3M$1.3M2025
Liabilities$7.3M$7.3M2025
Equity-$6.0M-$6.0M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Guided Therapeutics, Inc.’s revenue?
Guided Therapeutics, Inc. booked $767.0k in FY2025 revenue, growing 10857% year over year — faster than 99% of Healthcare companies we track, at a -416.7% net margin.
Peers · Healthcare
Rising Biosciences, Inc.——Tivic Health Systems, Inc.34DParadigm Medical Industries, Inc.——Bio Green Med Solution, Inc.48DWearable Health Solutions, Inc.——Dogecoin Cash, Inc.39DNeighbors
Gwinnett →Key facts
CEOMark L. Faupel
SectorHealthcare
IndustryMedical - Devices
HeadquartersNorcross, GA
ExchangeOTC: GTHP
Employees3
IPO date2021-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.